Sino Biological™ DLL4 Recombinant Human Protein, hIgG1-Fc Tag Non-distribution product as customer accommodation.

This recombinant human protein is expressed from a DNA sequence encoding the extracellular domain (Met 1-Pro 524) of human DLL4 preprotein (NP_061947.1) fused to the Fc region of human IgG1 at the C-terminus

Manufacturer: Invitrogen 10171H02H5

 View more versions of this product

Catalog No. 10-171-H02H5

  Check Availability
Add to Cart

Disclaimers:

For Research Use Only. Not for use in diagnostic procedures.


    Specifications

    For Use With (Application) Proteins, Expression, Isolation & Analysis; Enzyme & Protein Activity Assays; Protein Assay Controls, Reference Standards & Accessories
    Format Lyophilized
    Molecular Weight 81kDa
    Purity ≥90% by SDS-PAGE
    Quantity 5μg
    Storage Requirements Store at -20°C. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles. Expires one year from date of receipt when stored as instructed.
    Protein Subtype Neurotrophic Factors
    Endotoxin Concentration <1 EU/μg
    Gene Alias DLL4, mgC126344, hdelta2
    Common Name Delta-like 4 (Drosophila)
    Gene Symbol DLL4
    Protein Tag IgG1 Fc Tag
    Validated Application Assay Standard
    Protein Family Other Proteins
    Expression System Mammalian

    Delta-like 4 (Drosophila) (DLL4) recombinant human protein is supplied as a lyophilized powder. This protein is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications.Background: Delta-like protein 4 (DLL4) is a type I membrane-bound Notch ligand characterized by an extracellular region containing several EGF-like domains and a DSL domain required for receptor binding, and is suggested to play a key role in vascular development and tumorangiogenesis. The Notch pathway is an evolutionary conserved intercellular signaling pathway involved in numerous biological processes including cell fate determination, cellular differentiation, proliferation, survival, and apoptosis. In mammalian cells, five Notch ligands (Jagged1, 2, DLL1, 3, 4) and four Notch receptors (Notch1-4) have been identified, and ligand-receptor interactions results in proteolysis and translocation of the Notch intracellular domain. As a ligand for Notch1 and Notch 4, DLL4 is selectively expressed in the developing endothelium and in some tumor endothelium, and is induced by vascular endothelial growth factor (VEGF)-A and hypoxia. In recent studies, it has been revealed that this DLL4 inhibition may paradoxically lead to increased angiogenesis but poor tumor growth because of the nonfunctional neovascularization, and constitutive expression of DLL4 may lead to a lethal lymphoproliferative disease. Accordingly, this may provide a new therapeutic approach for certain carcinomas.

    • N-terminal Sequence Analysis: Ser 27
    • Activity: measured by its binding ability in a functional ELISA; immobilized human DLL4 at 10µg/mL (100µL/well) has been shown to bind biotinylated mouse NOTCH1-His, the EC50 of biotinylated mouse NOTCH1-His is 40ng/mL
    • Formulation: lyophilized in 140mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4, 5% mannitol, 5% trehalose, 0.02% Tween®-80
    • Reconstitution: Dissolve the protein in sterile double-distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

    Manufactured by Sino Biological (China).

  • Description & Specifications

Related Products


Product Content Feedback

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit